PP093-SUN A CANCER-SPECIFIC ENTERAL NUTRITION FORMULA IMPROVES NUTRITIONAL STATUS AND FUNCTIONAL PERFORMANCE IN PATIENTS WITH HEAD AND NECK AND OESOPHAGEAL CANCER UNDERGOING CHEMORADIOTHERAPY – A RANDOMISED, CONTROLLED MULTICENTER TRIAL
Dorota Łubgan(Universitätsklinikum Erlangen), Rainer Fietkau(Friedrich-Alexander-Universität Erlangen-Nürnberg), Marcus Niewald(Saarland University), Thomas Kuhnt(Leipzig University), Bo Berger, Victor Lewitzki(Universitätsklinikum Würzburg), T. Wiegel, Robert Michael Hermann(Providence Portland Medical Center), Tobias Hölscher(University Hospital Carl Gustav Carus), Ch. Hess, Claus Rödel(Goethe University Frankfurt)
Cited by 1
Related Papers
Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO/ARO/AIO-04 study): final results of the multicentre, open-label, randomised, phase 3 trial
|The Lancet Oncology|2015|723
European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2023 Guidelines
|European Urology|2023|656
Randomized Phase II Trial of Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer: CAO/ARO/AIO-12
|Journal of Clinical Oncology|2019|550
Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Patients With Locally Advanced Rectal Cancer
|JAMA Oncology|2021|369
The 2021 Updated European Association of Urology Guidelines on Metastatic Urothelial Carcinoma
|European Urology|2021|298